Clinical Trial

Cardiac Autonomic Dysfunction As a Sign of Irreversible Advanced Heart Failure

Study acronym: CADYSH
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 25, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The main hypothesis is that autonomic dysfunction cannot improve among patients reaching end-stage heart failure. To evaluate this, patients admitted with acute decompensated heart failure in Bispebjerg hospital, and history one or more admissions with the same condition within the prior year, will undergo repeated brief heart monitoring (10 min). Baseline recordings (at admission) will be compared with equivalent measurements before discharge to explore whether heart rate variability increases. Patients will be followed for six months after discharge from the hospital.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-31; most recent amendment 2025-02-22.
Status change: Not Yet Recruiting → Recruiting 2024-08-01
Trial Details
NCT Number NCT06532825
Lead Sponsor University Hospital Bispebjerg and Frederiksberg
Conditions Heart Failure
Enrollment 200 participants
Start Date 2024-08-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-25